In ₹ Crore except Per Share Latest Annual | NESCO FY26 | MSTCLTD FY26 | MEDPLUS FY26 | MANYAVAR FY25 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | ◆ 18.61× | 23.65× | 35.94× | 35.88× | 35.88× -48% | |
| P/B | ◆ 2.56× | 5.72× | 4.01× | — | 4.86× -47% | |
| EV/EBITDA | 14.90× | 21.23× | ◆ 12.69× | — | 16.96× -12% | |
| Market Cap | ₹7,679 Cr | ₹5,167 Cr | ₹7,909 Cr | — | ₹6,538 Cr +17% | |
| Growth | ||||||
| Revenue CAGR 3Y | ◆ 19.51% | -19.96% | 14.78% | 10.03% | 10.03% +95% | |
| Revenue CAGR 5Y | ◆ 26.21% | -13.88% | 17.56% | — | 1.84% +1324% | |
| Net Income CAGR 3Y | 12.40% | -3.35% | ◆ 63.65% | 7.25% | 7.25% +71% | |
| Revenue YoY (latest Q) | 9.55% | 21.72% | 21.84% | ◆ 22.74% | 21.84% -56% | |
| Net Income YoY (latest Q) | 3.97% | ◆ 37.50% | -21.67% | 37.31% | 37.31% -89% | |
| Profitability | ||||||
| EBITDA Margin | 52.61% | ◆ 60.63% | 8.81% | 46.35% | 46.35% +14% | |
| Net Income Margin | 44.28% | ◆ 59.09% | 3.19% | 28.02% | 28.02% +58% | |
| Return on Common Equity | 13.77% | ◆ 24.16% | 11.12% | 21.75% | 21.75% -37% | |
| Return on Capital Employed | 12.65% | ◆ 22.87% | 10.01% | 20.87% | 20.87% -39% | |
| Return on Assets | 11.19% | 10.86% | 5.58% | ◆ 14.14% | 10.86% +3% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.00× | 0.16× | 0.00× | — | 0.08× -100% | |
| Interest Coverage | ◆ 17.49× | — | 2.69× | 8.87× | 5.78× +203% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹932 Cr | ₹370 Cr | ₹6,892 Cr | ₹1,386 Cr | ₹1,386 Cr -33% | |
| Net Income | ₹413 Cr | ₹218 Cr | ₹220 Cr | ₹388 Cr | ₹220 Cr +88% | |
| Total Assets | ₹3,689 Cr | ₹2,011 Cr | ₹3,933 Cr | ₹2,747 Cr | ₹2,747 Cr +34% | |
| EPS | ₹58.58 | ₹31.03 | ₹18.33 | ₹15.99 | ₹18.33 +220% | |
| Book Value per Share | ₹425.33 | ₹128.4 | ₹164.48 | — | ₹146.44 +190% | |